Hydrocephalus Shunts Market by Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal) and Age Group (Infants, Children, and Adults) - Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4162550
- 181 Pages
- October 2020
- Pharmaceuticals
The global hydrocephalus shunts market was valued at $291.00 million in 2019 and is projected to reach $322.01 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Growth in the number of hydrocephalic patients across the world majorly drives the growth of the hydrocephalus shunts market. For instance, according to the National Institute of Neurological Disorders and Stroke, in 2020, 1 to 2 of every 1000 babies are born with hydrocephalus, globally. Thus, considering the total number of newborns per year, the prevalence of hydrocephalus is all set to increase in the future. Furthermore, a rise in cases of neurological disorders, owing to congenital abnormalities and lifestyle diseases as well as a rise in incidences of brain and nerve injuries, boosts the demand for hydrocephalic shunts. In addition, the use of advanced programmable valves helps neurosurgeons to externally adjust valve pressure used in shunts during the treatment. This thereby helps in controlling over-draining and under-draining issues associated with fixed pressure valves, which, in turn, is expected to drive the growth of the hydrocephalic shunts market. In addition, the use of programmable valves in treating hydrocephalus is anticipated to gain popularity in the coming years as most the medical professionals are opting for programmable shunts to reduce infections and malfunctions caused due to repetitive shunt surgeries. However, serious damages caused by infections and malfunctions of existing shunts greatly limit market growth. Some deleterious complications include irreversible brain injuries, meningitis, endocarditis, traumatic perforation, tricuspid regurgitation, heart failure, pulmonary hypertension, and others.
On the contrary, advancements in shunt technology for reducing shunt complications are projected to create lucrative opportunities for market growth.
The global hydrocephalus shunts market is segmented on the basis of type, age group, and region. By type, the market is classified into ventriculo-peritoneal shunts, ventriculo-atrial shunts, ventriculo-pleural shunts, and lumbo-peritoneal shunts. By age group, the hydrocephalus shunts market is categorized into infants, children, and adults. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2027, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global hydrocephalus shunt market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
• By Type
o Ventriculo-peritoneal
o Ventriculo-atrial
o Ventriculo-pleural
o Lumbo-peritoneal
• By Age Group
o Infants
o Children
o Adults
• By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
UK
France
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
• Christoph Miethke GmbH & Co. KG
• G. Surgiwear Ltd.
• HLL Lifecare Limited
• HpBio Próteses, Inc.
• Integra Life Sciences
• Kaneka Medix Corporation
• Medtronic plc
• Natus Medical Incorporated
• Spiegelberg GmbH & CO. KG
• Tokibo Co., Ltd.
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Growth in prevalence of hydrocephalus
3.4.1.2.Surge in adoption of advanced programmable valves
3.4.1.3.Increase in incidences of neurological disorders
3.4.2.Restraints
3.4.2.1.Shunt malfunction and related infections
3.4.2.2.Shunt-free treatments for hydrocephalus
3.4.3.Opportunity
3.4.3.1.Advancements in smart shunt technology
3.5.Top player positioning
3.6.Procedural Information
3.6.1.North America
3.6.2.Europe
3.6.3.Asia-Pacific
3.6.4.LAMEA
3.7.COVID-19 Impact on the market
CHAPTER 4:HYDROCEPHALUS SHUNT MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Ventriculo-peritoneal (VP) shunts
4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Ventriculo-atrial (VA) shunts
4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Ventriculo-pleural (VPL) shunts
4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.5.Lumbo-peritoneal (LP) shunts
4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
CHAPTER 5:HYDROCEPHALUS SHUNT MARKET, BY AGE GROUP
5.1.Overview
5.1.1.Market size and forecast
5.2.Infants
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Children
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Adults
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
CHAPTER 6:HYDROCEPHALUS SHUNTS MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by country
6.2.3.North America hydrocephalus shunts market, by type
6.2.4.North America hydrocephalus shunts market, by age group
6.2.5.U.S.
6.2.5.1.U.S. hydrocephalus shunts market, by type
6.2.5.2.U.S. hydrocephalus shunts market, by age group
6.2.6.Canada
6.2.6.1.Canada hydrocephalus shunts market, by type
6.2.6.2.Canada hydrocephalus shunts market, by age group
6.2.7.Mexico
6.2.7.1.Mexico hydrocephalus shunts market, by type
6.2.7.2.Mexico hydrocephalus shunts market, by age group
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by country
6.3.3.Europe hydrocephalus shunts market, by type
6.3.4.Europe hydrocephalus shunts market, by age group
6.3.5.Germany
6.3.5.1.Germany hydrocephalus shunts market, by type
6.3.5.2.Germany hydrocephalus shunts market, by age group
6.3.6.France
6.3.6.1.France hydrocephalus shunts market, by type
6.3.6.2.France hydrocephalus shunts market, by age group
6.3.7.UK
6.3.7.1.UK hydrocephalus shunts market, by type
6.3.7.2.UK hydrocephalus shunts market, by age group
6.3.8.Italy
6.3.8.1.Italy hydrocephalus shunts market, by type
6.3.8.2.Italy hydrocephalus shunts market, by age group
6.3.9.Spain
6.3.9.1.Spain hydrocephalus shunts market, by type
6.3.9.2.Spain hydrocephalus shunts market, by age group
6.3.10.Rest of Europe
6.3.10.1.Rest of Europe hydrocephalus shunts market, by type
6.3.10.2.Rest of Europe hydrocephalus shunts market, by age group
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast, by country
6.4.3.Asia-Pacific hydrocephalus shunts market, by type
6.4.4.Asia-Pacific hydrocephalus shunts market, by age group
6.4.5.Japan
6.4.5.1.Japan hydrocephalus shunts market, by type
6.4.5.2.Japan hydrocephalus shunts market, by age group
6.4.6.China
6.4.6.1.China hydrocephalus shunts market, by type
6.4.6.2.China hydrocephalus shunts market, by age group
6.4.7.India
6.4.7.1.India hydrocephalus shunts market, by type
6.4.7.2.India hydrocephalus shunts market, by age group
6.4.8.Australia
6.4.8.1.Australia hydrocephalus shunts market, by type
6.4.8.2.Australia hydrocephalus shunts market, by age group
6.4.9.South Korea
6.4.9.1.South Korea hydrocephalus shunts market, by type
6.4.9.2.South Korea hydrocephalus shunts market, by age group
6.4.10.Rest of Asia-Pacific
6.4.10.1.Rest of Asia-Pacific hydrocephalus shunts market, by type
6.4.10.2.Rest of Asia-Pacific hydrocephalus shunts market, by age group
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast, by country
6.5.3.LAMEA hydrocephalus shunts market, by type
6.5.4.LAMEA hydrocephalus shunts market, by age group
6.5.5.Brazil
6.5.5.1.Brazil hydrocephalus shunts market, by type
6.5.5.2.Brazil hydrocephalus shunts market, by age group
6.5.6.Saudi Arabia
6.5.6.1.Saudi Arabia hydrocephalus shunts market, by type
6.5.6.2.Saudi Arabia hydrocephalus shunts market, by age group
6.5.7.South Africa
6.5.7.1.South Africa hydrocephalus shunts market, by type
6.5.7.2.South Africa hydrocephalus shunts market, by age group
6.5.8.Rest of LAMEA
6.5.8.1.Rest of LAMEA hydrocephalus shunts market, by type
6.5.8.2.Rest of LAMEA hydrocephalus shunts market, by age group
CHAPTER 7:COMPANY PROFILES
7.1.CHRISTOPH MIETHKE GmbH & CO. KG
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Business performance
7.1.5.Key strategic moves and developments
7.2.G. SURGIWEAR LTD.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Business performance
7.3.HLL LIFECARE LIMITED
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Business performance
7.4.HPBIO PRÓTESES, INC.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Business performance
7.5.INTEGRA LIFE SCIENCES
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Business performance
7.5.5.Key strategic moves and developments
7.6.KANEKA MEDIX CORPORATION
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Business performance
7.7.MEDTRONIC PLC
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Business performance
7.8.NATUS MEDICAL INCORPORATED
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Business performance
7.8.5.Key strategic moves and developments
7.9.SPIEGELBERG GmbH & CO. KG
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Business performance
7.10.TOKIBO CO., LTD
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Business performance
TABLE 01.HYDROCEPHALUS SHUNT PROCEDURES, 2019–2027 ($MILLION)
TABLE 02.HYDROCEPHALUS SHUNT PROCEDURES, 2019–2027 ($MILLION)
TABLE 03.HYDROCEPHALUS SHUNT PROCEDURES, 2019–2027 ($MILLION)
TABLE 04.HYDROCEPHALUS SHUNT PROCEDURES, 2019–2027 ($MILLION)
TABLE 05.HYDROCEPHALUS SHUNT PROCEDURES, 2019–2027 ($MILLION)
TABLE 06.HYDROCEPHALUS SHUNT: OVERVIEW
TABLE 07.HYDROCEPHALUS SHUNT MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.HYDROCEPHALUS SHUNT MARKET FOR VENTRICULO-PERITONEAL (VP) TYPE, BY REGION, 2019–2027 ($MILLION)
TABLE 09.HYDROCEPHALUS SHUNT MARKET FOR VENTRICULO-ATRIAL (VA) TYPE, BY REGION, 2019–2027 ($MILLION)
TABLE 10.HYDROCEPHALUS SHUNT MARKET FOR VENTRICULO-PLEURAL (VPL) TYPE, BY REGION, 2019–2027 ($MILLION)
TABLE 11.HYDROCEPHALUS SHUNT MARKET FOR LUMBO-PERITONEAL (LP) TYPE, BY REGION, 2019–2027 ($MILLION)
TABLE 12.HYDROCEPHALUS SHUNT MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 13.HYDROCEPHALUS SHUNT MARKET FOR INFANT, BY REGION, 2019–2027 ($MILLION)
TABLE 14.HYDROCEPHALUS SHUNT MARKET FOR CHILDREN, BY REGION, 2019–2027 ($MILLION)
TABLE 15.HYDROCEPHALUS SHUNT MARKET FOR ADULT, BY REGION, 2019–2027 ($MILLION)
TABLE 16.HYDROCEPHALUS SHUNTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 17.NORTH AMERICA HYDROCEPHALUS SHUNTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 18.NORTH AMERICA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 19.NORTH AMERICA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 20.U.S. HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 21.U.S. HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 22.CANADA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 23.CANADA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 24.MEXICO HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 25.MEXICO HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 26.EUROPE HYDROCEPHALUS SHUNTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 27.EUROPE HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 28.EUROPE HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 29.GERMANY HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 30.GERMANY HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 31.FRANCE HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 32.FRANCE HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 33.UK HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 34.UK HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 35.ITALY HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 36.ITALY HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 37.SPAIN HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 38.SPAIN HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 39.REST OF EUROPE HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 40.REST OF EUROPE HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 41.ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 42.ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 43.ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 44.JAPAN HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 45.JAPAN HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 46.CHINA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 47.CHINA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 48.INDIA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 49.INDIA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 50.AUSTRALIA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 51.AUSTRALIA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 52.SOUTH KOREA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 53.SOUTH KOREA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 54.REST OF ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 55.REST OF ASIA-PACIFIC HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 56.LAMEA HYDROCEPHALUS SHUNTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 57.LAMEA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 58.LAMEA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 59.BRAZIL HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 60.BRAZIL HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 61.SAUDI ARABIA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 62.SAUDI ARABIA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 63.SOUTH AFRICA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 64.SOUTH AFRICA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 65.REST OF LAMEA HYDROCEPHALUS SHUNTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 66.REST OF LAMEA HYDROCEPHALUS SHUNTS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 67.MIETHKE: COMPANY SNAPSHOT
TABLE 68.MIETHKE: OPERATING SEGMENTS
TABLE 69.G. SURGIWEAR: COMPANY SNAPSHOT
TABLE 70.G. SURGIWEAR: OPERATING SEGMENTS
TABLE 71.HLL LIFECARE LIMITED: COMPANY SNAPSHOT
TABLE 72.HLL LIFECARE LIMITED: OPERATING SEGMENTS
TABLE 73.HPBIO PRÓTESES, INC.: COMPANY SNAPSHOT
TABLE 74.HPBIO PRÓTESES, INC.: OPERATING SEGMENTS
TABLE 75.INTEGRA LIFE SCIENCES: COMPANY SNAPSHOT
TABLE 76.INTEGRA LIFE SCIENCES: OPERATING SEGMENTS
TABLE 77.KANEKA: COMPANY SNAPSHOT
TABLE 78.KANEKA: OPERATING SEGMENTS
TABLE 79.MEDTRONIC: COMPANY SNAPSHOT
TABLE 80.MEDTRONIC: OPERATING SEGMENTS
TABLE 81.NATUS MEDICAL: COMPANY SNAPSHOT
TABLE 82.NATUS MEDICAL: OPERATING SEGMENTS
TABLE 83.SPIEGELBERG: COMPANY SNAPSHOT
TABLE 84.SPIEGELBERG: OPERATING SEGMENTS
TABLE 85.TOKIBO: COMPANY SNAPSHOT
TABLE 86.G. SURGIWEAR: OPERATING SEGMENTS
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
